Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
6 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
Inhibition of SYK or BTK augments venetoclax sensitivity in SHP1-negative/BCL-2-positive diffuse large B-cell lymphoma.
Leukemia. 2019 Oct;33(10):2416-2428. doi: 10.1038/s41375-019-0442-8. Epub 2019 Mar 14.
Leukemia. 2019.
PMID: 30872780
Mechanisms of B Cell Receptor Activation and Responses to B Cell Receptor Inhibitors in B Cell Malignancies.
Efremov DG, Turkalj S, Laurenti L.
Efremov DG, et al. Among authors: turkalj s.
Cancers (Basel). 2020 May 28;12(6):1396. doi: 10.3390/cancers12061396.
Cancers (Basel). 2020.
PMID: 32481736
Free PMC article.
Review.
Item in Clipboard
A protocol for simultaneous high-sensitivity genotyping and chromatin accessibility profiling in single cells.
Turkalj S, Jakobsen NA, Groom A, Radtke FA, Vyas P.
Turkalj S, et al.
STAR Protoc. 2023 Dec 15;4(4):102641. doi: 10.1016/j.xpro.2023.102641. Epub 2023 Oct 26.
STAR Protoc. 2023.
PMID: 37897733
Free PMC article.
Item in Clipboard
An Overview of Targeted Therapies in Acute Myeloid Leukemia.
Turkalj S, Radtke FA, Vyas P.
Turkalj S, et al.
Hemasphere. 2023 May 26;7(6):e914. doi: 10.1097/HS9.0000000000000914. eCollection 2023 Jun.
Hemasphere. 2023.
PMID: 37304938
Free PMC article.
Review.
Item in Clipboard
GTAC enables parallel genotyping of multiple genomic loci with chromatin accessibility profiling in single cells.
Turkalj S, Jakobsen NA, Groom A, Metzner M, Riva SG, Gür ER, Usukhbayar B, Salazar MA, Hentges LD, Mickute G, Clark K, Sopp P, Davies JOJ, Hughes JR, Vyas P.
Turkalj S, et al.
Cell Stem Cell. 2023 May 4;30(5):722-740.e11. doi: 10.1016/j.stem.2023.04.012.
Cell Stem Cell. 2023.
PMID: 37146586
Free article.
Item in Clipboard
A Phase Ib/II Study of Ivosidenib with Venetoclax ± Azacitidine in IDH1-Mutated Myeloid Malignancies.
Lachowiez CA, Loghavi S, Zeng Z, Tanaka T, Kim YJ, Uryu H, Turkalj S, Jakobsen NA, Luskin MR, Duose DY, Tidwell RSS, Short NJ, Borthakur G, Kadia TM, Masarova L, Tippett GD, Bose P, Jabbour EJ, Ravandi F, Daver NG, Garcia-Manero G, Kantarjian H, Garcia JS, Vyas P, Takahashi K, Konopleva M, DiNardo CD.
Lachowiez CA, et al. Among authors: turkalj s.
Blood Cancer Discov. 2023 Jul 5;4(4):276-293. doi: 10.1158/2643-3230.BCD-22-0205.
Blood Cancer Discov. 2023.
PMID: 37102976
Free PMC article.
Clinical Trial.
Item in Clipboard
Cite
Cite